The following speakers have received an honorarium from Novo Nordisk for their input to and facilitation of this educational material:
- Prof. Aleksander Krag, University of Southern Denmark, Odense University Hospital, Denmark
- Prof. Juan Mendive, Catalan Institute of Health, University of Barcelona
- Prof. Geltrude Mingrone, King’s College London, UK, and Università Cattolica del S. Cuore, Italy
- Dr Arun Sanyal, Virginia Commonwealth University School of Medicine, Richmond, United States of America
1. Younossi ZM, et al. Hepatology. 2023;77:1335–1347
2. Yanai H, et al. Int J Mol Sci. 2023;24:15473; doi: 10.3390/ijms242015473
- To raise awareness of MASLD/MASH as a manifestation of metabolic disease
- To improve understanding of risk factors and comorbidities for MASLD/MASH and the progressive nature of steatotic liver diseases
- To highlight the role of primary care, endocrinology and hepatology in the diagnosis and management of people with MASLD/MASH
